EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients

Launched by FONDAZIONE DON CARLO GNOCCHI ONLUS · Aug 3, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a special exercise called Nordic Walking (NW) on overweight or obese patients with diabetes and heart issues. Nordic Walking involves using special sticks while walking, which helps to burn more calories and strengthens various muscles in the body. The trial aims to see how well this exercise improves heart health, safety, and how likely participants are to stick with the program over six and twelve months compared to standard rehabilitation training and basic exercise advice.

To be part of this study, participants should be adults aged 65 to 74 who are overweight or obese and have diabetes, along with a recent heart event like a heart attack or heart surgery. Those who cannot walk independently or have certain health conditions that restrict movement may not be eligible. Participants will engage in a three-month Nordic Walking program, guided by an instructor, and will be monitored over the following year to evaluate their progress. This trial offers a chance to improve health while learning a fun and safe way to exercise.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - overweight \[Body Mass Index (BMI) ≥ 27 kg/m2\] or obese (BMI ≥30 kg/m2) adult patients with diabetes mellitus and with a recent cardiovascular event and/or coronary revascularization in the previous three months
• Exclusion Criteria:
• • inability to walk independently and constantly;
• • acute joint or spine pathologies that make movement impossible;
• • the presence of dementia as approved by consultation of the patient's medical record and/or administration of the Montreal Cognitive Assessment (MOCA) test ≤ 15.5 (Nasreddine et al., 2005);
• • chemotherapy 6 months before surgery;
• • advanced renal failure;
• • acute cardiovascular event \< 3 months (unstable angina, AMI with FE \<40%, arrhythmias, valvular disease, intracerebral/subdural haemorrhage, uncontrolled AI);
• • home oxygen therapy and Non-Invasive Ventilation (NIV) \[excluding Continuous Positive Airway Pressure (CPAP)\].